These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16873897)

  • 1. Institution/investigator-initiated clinical trials in Canada.
    Sedgeworth J; Derewlany L
    Can J Clin Pharmacol; 2006; 13(2):e236-9. PubMed ID: 16873897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The other side of clinical trial monitoring; assuring data quality and procedural adherence.
    Williams GW
    Clin Trials; 2006; 3(6):530-7. PubMed ID: 17170037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical equipoise and notions of expertise: how law may inform ideas in ethics.
    Campbell A
    Health Law Rev; 2000; 8(3):11-24. PubMed ID: 15706704
    [No Abstract]   [Full Text] [Related]  

  • 4. [Key points in the start and conduct of a clinical trial. From question to reality in an investigator-initiated clinical trial (I)].
    Tur J; Escudero A; Iglesias L; Alos M; Luque L; Burguera B
    Endocrinol Nutr; 2011; 58(6):291-8. PubMed ID: 21514906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
    Ellenberg SS; George SL
    Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Constraints on publication rights in industry-initiated clinical trials--secondary publication].
    Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW
    Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials profile: professionals and sites.
    Paschoale HS; Barbosa FR; Nita ME; Carrilho FJ; Ono-Nita SK
    Contemp Clin Trials; 2010 Sep; 31(5):438-42. PubMed ID: 20601160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Marketing of researchers--lack of judgment or a new trend?].
    Werkö L; Hernborg A; Liedholm H; Melander A
    Lakartidningen; 2002 Apr; 99(17):1962-3. PubMed ID: 12043423
    [No Abstract]   [Full Text] [Related]  

  • 9. What information should a sponsor of a randomized trial receive during its conduct?
    Anand SS; Wittes J; Yusuf S
    Clin Trials; 2011 Dec; 8(6):716-9. PubMed ID: 22024103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of the French network of paediatric clinical investigation centres (CIC.P).
    Jacqz-Aigrain E; Kassai B;
    Fundam Clin Pharmacol; 2007 Apr; 21(2):105-10. PubMed ID: 17391283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of highly specialized clinical drug trial units within health care institutions].
    Stanimirović V; Babić M; Nikolić D; Cucak S; Nikolić A
    Srp Arh Celok Lek; 2000; 128(7-8):253-8. PubMed ID: 11089432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials bureaucracy: unintended consequences of well-intentioned policy.
    Califf RM
    Clin Trials; 2006; 3(6):496-502. PubMed ID: 17170032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current controversies in data monitoring for clinical trials.
    Pocock SJ
    Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do we need noncommercial, investigator-initiated clinical trials?
    Tyndall A
    Nat Clin Pract Rheumatol; 2008 Jul; 4(7):354-5. PubMed ID: 18477999
    [No Abstract]   [Full Text] [Related]  

  • 15. The many moral responsibilities of independent data-monitoring committees.
    Braillon A
    Am J Bioeth; 2011 Mar; 11(3):16-7. PubMed ID: 21400378
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific barriers to the conduct of randomized trials.
    Duley L; Antman K; Arena J; Avezum A; Blumenthal M; Bosch J; Chrolavicius S; Li T; Ounpuu S; Perez AC; Sleight P; Svard R; Temple R; Tsouderous Y; Yunis C; Yusuf S
    Clin Trials; 2008; 5(1):40-8. PubMed ID: 18283079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.
    Landewé RB; Smolen JS; Weinblatt ME; Emery P; Dougados M; Fleischmann R; Aletaha D; Kavanaugh A; van der Heijde D
    Ann Rheum Dis; 2014 Oct; 73(10):1755-60. PubMed ID: 25114058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striding forward or getting too big for their boots? The developing role of data monitoring committees in clinical trials.
    Tharmanathan P; Calvert MJ; Freemantle N
    J Clin Pharm Ther; 2006 Apr; 31(2):111-8. PubMed ID: 16635044
    [No Abstract]   [Full Text] [Related]  

  • 19. Strength of accumulating evidence and data monitoring committee decision making.
    George SL; Freidlin B; Korn EL
    Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigator responsibilities for clinical research studies: proper staffing can ensure an investigator is compliant.
    Kee AN
    J Med Pract Manage; 2011; 26(4):245-7. PubMed ID: 21506468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.